Clinical trials: Prostatic Hypertrophy, Benign

Prostate Disease, BPH

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

• Completed
• Age: 50 to 80 years
• Phase 1/2

Multi-center, prospective randomized dosing and safety research study. A maximum of 150 men will be enrolled in the study. Qualifying patients will receive one of three possible doses of the study drug.

Conditions

Prostate Disease, BPH, Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy

Trial name

NCT00037141

Testing

dehydrated alcohol

Volunteers

150 people

Sponsor

American Medical Systems